Clover Health Investments (CLOV) Income Annual - Discounting Cash Flows
Clover Health Investments, Corp.
CLOV (NASDAQ)

* (except for per share items) of USD
Period Ending: LTM
(Last Twelve Months)
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
Report Filing 2024-03-14 2023-03-01 2022-02-28 2021-03-31 2019-12-31 2018-12-31
Revenue
2,034 3,477 1,472 673 462 281
Cost of Revenue
1,776 3,454 1,551 590 450 0.00
Gross Profit
257 22.7 -79.2 82.4 12.6 281
Operating Expenses
466 394 558 175 196 467
Research & Development
0.00 0.00 0.00 0.00 0.00 0.00
Selling, General and Administrative
445 487 446 192 187 187
Other Operating Expenses
21.1 -93.0 112 -16.6 8.44 280
Operating Income
-209 -371 -637 -92.7 -183 -186
Net Non-Operating Interest
-0.01 0.00 0.00 -57.0 0.00 6.95
Interest Income
0.00 1.36 16.9 0.12 39.1 6.95
Interest Expense
0.01 1.36 16.9 57.1 39.1 0.00
Equity & Other Income/(Expense)
-4.81 32.1 49.2 58.1 -181 -23.1
Income Before Tax
-213 -339 -588 -91.6 -364 -202
Income Tax Expense
0.00 -33.4 16.9 57.1 39.1 -16.1
Income Attributable to Non-Controlling Interest
0.00 0.00 0.00 0.00 0.00 16.1
Net Income
-213 -305 -605 -149 -403 -202
Depreciation and Amortization
2.51 1.19 1.25 0.56 0.55 186
EBITDA
-206 -370 -636 -92.2 -183 0.00
Earnings Per Share (EPS)
-0.440 -0.640 -1.460 -1.680 -3.890 -4.810
Diluted Earnings Per Share
-0.440 -0.640 -1.460 -1.680 -3.890 -4.810
Weighted Average Shares Outstanding
482 476 413 88.7 104 42.0
Diluted Weighted Average Shares Outstanding
482 476 413 88.7 104 42.0
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us